These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 6832406)
1. Effects of oral contraceptives on serum lipid profiles of women runners. Gray DP; Harding E; Dale E Fertil Steril; 1983 Apr; 39(4):510-4. PubMed ID: 6832406 [TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
4. Effect of a controlled exercise program on serum lipoprotein levels in women on oral contraceptives. Wynne TP; Frey MA; Laubach LL; Glueck CJ Metabolism; 1980 Dec; 29(12):1267-71. PubMed ID: 7453571 [TBL] [Abstract][Full Text] [Related]
5. Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study. Greenlund KJ; Webber LS; Srinivasan S; Wattigney W; Johnson C; Berenson GS Ann Epidemiol; 1997 Nov; 7(8):561-7. PubMed ID: 9408552 [TBL] [Abstract][Full Text] [Related]
6. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases. Cai HJ; Li ZX; Yang SM Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460 [TBL] [Abstract][Full Text] [Related]
7. The effect of triphasic and biphasic oral contraceptive preparations on HDL-cholesterol and LDL-cholesterol in young women. Percival-Smith RK; Morrison BJ; Sizto R; Abercrombie B Contraception; 1987 Feb; 35(2):179-87. PubMed ID: 3595143 [TBL] [Abstract][Full Text] [Related]
8. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257 [TBL] [Abstract][Full Text] [Related]
9. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives. Oyelola OO Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671 [TBL] [Abstract][Full Text] [Related]
10. The interaction of alcohol consumption and oral contraceptive use on lipids and lipoproteins. Kruszon-Moran D; Burkman RT; Kimball AW; Bachorik PS; Gold EB Contraception; 1988 Jan; 37(1):39-51. PubMed ID: 3365983 [TBL] [Abstract][Full Text] [Related]
11. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins. Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183 [TBL] [Abstract][Full Text] [Related]
12. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy. Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348 [TBL] [Abstract][Full Text] [Related]
13. [Lipids, lipoproteins, arterial accidents and oral contraceptives]. Bakir R; Hilliquin P Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243 [TBL] [Abstract][Full Text] [Related]
14. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism. Walsh BW; Sacks FM J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779 [TBL] [Abstract][Full Text] [Related]
15. The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. Wynn V; Niththyananthan R Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):766-71. PubMed ID: 6801982 [TBL] [Abstract][Full Text] [Related]
16. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related]
17. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study. Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins. Ahrén T; Lithell H; Victor A; Vessby B; Johansson ED Contraception; 1981 Oct; 24(4):451-68. PubMed ID: 6797786 [TBL] [Abstract][Full Text] [Related]
19. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women. Straznicky NE; Barrington VE; Branley P; Louis WJ J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929 [TBL] [Abstract][Full Text] [Related]
20. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]